Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06747650 · ClinicalTrials.gov registry record · NA

Dialectical Behavior Therapy for Adolescents With Fetal Alcohol Spectrum Disorders Feasibility Trial

A NA study of Fetal Alcohol Spectrum Disorder, sponsored by University of Rochester.

Completed
Registry status
NA
Development phase
9
Enrollment target
1
Study location

NCT06747650 is a NA study of Fetal Alcohol Spectrum Disorder that has completed, run by University of Rochester. The registered enrollment target is 9 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06747650, a NA study of Fetal Alcohol Spectrum Disorder, has completed, sponsored by University of Rochester.

COMPLETED
Registry status
NA
Development phase
9 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to test the feasibility of dialectical behavior therapy for adolescents (DBT-A) with fetal alcohol spectrum disorders (FASD). In partnership with a community mental health practice, Genesee Valley Psychology (GVP), two cohorts of five adolescents with FASD and their caregivers will participate in an already existing comprehensive DBT-A program (including individual therapy, group skills training, and 24/7 phone coaching). This program has been adapted for neurodivergent teens, including the development of trainings for mental health clinicians on FASD. The aim of the current study is to assess the acceptability of DBT-A from the perspective of teens, caregivers, and clinicians. Additionally, barriers and facilitators of implementing DBT-A with teens with FASD, as well as the feasibility of the research protocol will be assessed to inform later larger-scale trials.

Interventions

  • BEHAVIORAL Dialectical Behavior Therapy for Adolescents

Study Locations (1)

New York

  • University of Rochester Medical Center - Rochester

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2024-12-24
Est. Completion 2025-10-29
Phase NA

Sponsor

University of Rochester

636 total trials

What the Registry Record Tells You About NCT06747650

The ClinicalTrials.gov registry entry for NCT06747650 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Fetal Alcohol Spectrum Disorder appearing as the primary indexed condition, and to 1 intervention - of which Dialectical Behavior Therapy for Adolescents is the first listed.

NCT06747650 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06747650 about?

NCT06747650 is a clinical study titled "Dialectical Behavior Therapy for Adolescents With Fetal Alcohol Spectrum Disorders Feasibility Trial". The purpose of this study is to test the feasibility of dialectical behavior therapy for adolescents (DBT-A) with fetal alcohol spectrum disorders (FASD). In partnership with a community mental health practice, Genesee Valley Psychology (GVP), two cohorts of five adolescents with FASD and their care...

What is the current status of trial NCT06747650?

This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2024-12-24. Estimated completion is 2025-10-29.

What conditions does trial NCT06747650 study?

This clinical trial studies the following conditions: Fetal Alcohol Spectrum Disorder.

What interventions are being tested in trial NCT06747650?

The interventions under investigation include: Dialectical Behavior Therapy for Adolescents (BEHAVIORAL).

Who is sponsoring clinical trial NCT06747650?

This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06747650 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.